At the time of writing, Inari Medical Inc [NARI] stock is trading at $43.07, down -0.23%. An important factor to consider is whether the stock is rising or falling in short-term value. The NARI shares have lost -0.37% over the last week, with a monthly amount glided 1.37%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 2, April 2024, Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives. In a post published today on Yahoo Finance, Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the appointment of Tim Benner as Senior Vice President of U.S. Sales and Dr. Andrew Niekamp as Vice President of Medical Affairs. Mr. Benner will be responsible for developing effective strategies across the company’s multi-product sales platform and leading a high-performance commercial team to drive therapy penetration. Dr. Niekamp will be instrumental in advancing Inari’s mission to improve patient care through physician education and new device development.
From an analyst’s perspective:
Inari Medical Inc [NASDAQ: NARI] stock has seen the most recent analyst activity on February 29, 2024, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $55 from $85. Previously, Needham started tracking the stock with Buy rating on January 23, 2024, and set its price target to $72. On July 19, 2023, Robert W. Baird initiated with a Outperform rating and assigned a price target of $79 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $88 on October 12, 2022. Berenberg initiated its recommendation with a Buy and recommended $85 as its price target on September 29, 2022. Truist started tracking with a Hold rating for this stock on September 13, 2022, and assigned it a price target of $87. In a note dated June 21, 2022, Piper Sandler initiated an Overweight rating and provided a target price of $100 on this stock.
For the past year, the stock price of Inari Medical Inc fluctuated between $39.90 and $71.85. Currently, Wall Street analysts expect the stock to reach $88 within the next 12 months. Inari Medical Inc [NASDAQ: NARI] shares were valued at $43.07 at the most recent close of the market. An investor can expect a potential return of 104.32% based on the average NARI price forecast.
Analyzing the NARI fundamentals
According to Inari Medical Inc [NASDAQ:NARI], the company’s sales were 493.63M for trailing twelve months, which represents an 22.57% jump. Gross Profit Margin for this corporation currently stands at 0.88% with Operating Profit Margin at -0.0%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.0 and Total Capital is -0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 42.38 points at the first support level, and at 41.70 for the second support level. However, for the 1st resistance point, the stock is sitting at 43.42, and for the 2nd resistance point, it is at 43.78.
Inari Medical Inc [NARI] reported earnings per share of -$0.08 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.01/share, meaning a difference of -$0.09 and a surprise factor of -900.00%.
Ratios To Look Out For
It is important to note that Inari Medical Inc [NASDAQ:NARI] has a current ratio of 3.09. On the other hand, the Quick Ratio is 2.52, and the Cash Ratio is 0.51. Considering the valuation of this stock, the price to sales ratio is 5.06, the price to book ratio is 5.35.
Transactions by insiders
Recent insider trading involved Hoffman William, Director, that happened on Mar 18 ’24 when 40000.0 shares were sold. Chief Financial Officer, Hill, Mitch C. completed a deal on Mar 12 ’24 to sell 6000.0 shares. Meanwhile, Director Hoffman William sold 25000.0 shares on Dec 15 ’23.
